Welcome to our dedicated page for Fortive SEC filings (Ticker: FTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fortive Corporation filings document the reporting, governance, capital structure, and material-event record of an industrial technology operating company. Form 8-K disclosures include quarterly and annual operating results, share repurchase activity, the financial presentation of continuing operations after the completed Ralliant separation, and updates tied to Fortive’s strategic segments.
The company’s SEC record also includes a definitive proxy statement covering director elections, executive compensation, equity awards, and shareholder voting matters. Other filings describe material financing arrangements, including a revolving credit agreement, senior note securities, and a Form 25 notice related to the listing and registration status of Fortive’s 3.700% Notes due 2026.
Fortive Corp. (FTV) – Form 4 insider transaction
Chief Financial Officer Mark D. Okerstrom reported an open-market purchase of 21,300 common shares on 01-Aug-2025 at a weighted-average price of $47.03 (price range $46.66–$47.24). The transaction lifts his direct ownership to 94,622 shares.
The share count incorporates additional Restricted Stock Units received through an anti-dilution adjustment tied to Fortive’s recent spin-off of Ralliant Corporation. No derivative securities were involved, and no sales were disclosed.
The filing was submitted by a single reporting person and contains no other material events.
Fortive’s Q2-25 results show modest top-line erosion and margin compression ahead of the Precision Technologies (PT) spin. Revenue slipped 2.2% YoY to $1.52 bn as softer product sales in PT (-5%) offset stable Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). Gross margin eased 80 bp to 59.0%, while operating margin contracted 480 bp to 14.6% on $41 m separation costs and higher SG&A. Net earnings fell 14.6% to $166.6 m; diluted EPS dropped to $0.49 (vs $0.55).
Cash strengthened but leverage ticked up. Operating cash flow of $552.9 m (-2% YoY) plus lower capex lifted cash & equivalents to $1.83 bn from $813 m at FY-24. Total debt rose to $4.81 bn (vs $3.71 bn) with $1.15 bn of new Ralliant term-loans classified as current until the 28 Jun 25 spin. Current debt therefore jumped to $1.91 bn. Net debt/EBITDA remains manageable at ~1.6× (pro-forma).
Strategic actions. On 28 Jun 25 Fortive completed the tax-free distribution of PT as Ralliant, receiving a $1.15 bn dividend which management is using to redeem €252 m of 3.7% notes, repay euro/yen term loans and fund a special share-repurchase program announced 27 May 25. Beginning Q3-25, Ralliant will be reported as discontinued operations, simplifying Fortive to IOS and AHS.
Liquidity & outlook. Undrawn $2.0 bn revolver backs commercial paper ($395 m outstanding). FX-translation gains added $178 m to AOCI. Management continues a discrete restructuring (charges: $12 m YTD) to resize post-spin cost base. No forward guidance was provided in the filing.
Fortive Corporation (FTV) – Form 4 insider transaction
On 07/02/2025 President & CEO Olumide Soroye received a new equity compensation package that includes:
- 33,100 Restricted Stock Units (RSUs) – issued in two tranches of 14,185 and 18,915 units, both time-based; RSUs settle one-for-one in common shares.
- 100,300 stock options – two grants for 42,990 and 57,310 shares at an exercise price of $53.34; options expire 07/02/2035 with multi-year vesting schedules (50 % vests on 3rd & 4th anniversaries for one grant; 50 %, 25 %, 25 % over years 1-3 for the other).
Following the RSU grants, Soroye’s direct ownership increased to 206,130 common shares. Option grants are non-cash awards and do not affect current share count until exercised, but they add to potential future dilution.
The company notes that share totals may be adjusted after the 06/28/2025 spin-off of Ralliant Corporation.
The filing represents routine executive compensation rather than an open-market purchase; market impact is likely limited.